More on IPXL

- Summary
- Chart
- Profile
- Historical


- Earnings (+18.2% Growth)
- Ratings (3.9 Score)
- Holders
- FDA Archive


Income Statement
Balance Sheet
Cash Flow Statement

Upcoming Events

- Earnings (11/9/15)


- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks

IPXL Balance Sheet

Click line-items for a historical chart and %
Current assets:
Cash and cash equivalents 190.29M
Short-term investments 0
Accounts receivable, net 241.72M
Inventory, net 123.43M
Deferred product manufacturing costs
Deferred income taxes 84.16M
Prepaid expenses and other current assets 63.42M
Total current assets 703.02M
Property, plant and equipment, net 214.63M
Deferred product manufacturing costs
Deferred income taxes, net 133K
Other assets 69.81M
Goodwill 157.27M
Total assets 2.03B
Current liabilities:
Accounts payable 29.87M
Accrued expenses 154.14M
Accrued income taxes payable
Accrued profit sharing and royalty expenses 41.66M
Deferred revenue 907K
Total current liabilities 226.58M
Deferred revenue 2.95M
Other liabilities 36.96M
Total liabilities 1.04B
Commitments and contingencies (Note 8) 0
Stockholders' equity:
Preferred Stock, $ 0.01 par value, 2,000,000 shares authorized, 0 shares outstanding at June 30, 2011 and December 31, 2010 0
Common stock, $ 0.01 par value, 90,000,000 shares authorized and 65,872,062 and 64,721,041 shares issued at June 30, 2011 and December 31, 2010, respectively 720K
Additional paid-in capital 468.51M
Treasury stock-243,729 shares -2.16M
Accumulated other comprehensive income -2.43M
Retained earnings 523.04M
Stockholders' Equity Attributable to Parent, Total
Noncontrolling interest
Total stockholders' equity 987.69M
Total liabilities and stockholders' equity 2.03B